BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated
diseases on opposite ends of the immune scale in kidney transplant recipients. The principle …

Tacrolimus, a calcineurin inhibitor, has been the cornerstone of immunosuppressive
regimens in renal transplant over 2 decades. This has significantly improved the outcomes …

Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …

Currently, kidney transplantation is the best treatment option for kidney failure for a majority
of eligible patients. It is associated with a better quality of life and reduced mortality as …

Tacrolimus has significantly improved outcomes for kidney transplant patients and remains
the cornerstone of immunosuppressive therapy. While improvements in short-term outcomes …

Background In a phase III, open-label, comparative, noninferiority study, 638 subjects
receiving de novo kidney transplants were randomized to one of three treatment arms …

Introduction Progressive multifocal leukoencephalopathy (PML) was first described among
patients affected by hematological or solid tumors. Following the human immunodeficiency …

Post-transplant diabetes mellitus (PTDM) is a frequent complication after kidney
transplantation (KT). This systematic review investigated the effect of different …

BACKGROUND End-stage renal disease is a long-term irreversible decline in kidney
function requiring renal replacement therapy: kidney transplantation, haemodialysis or …

Transplantation medicine is a rapidly evolving field. Kee** afloat of the published
literature to offer the best clinical care to our patients is a daunting task. As part of its …